Model predictions related to outcome in group of TKI-treated patients with no biopsy testing available. »
07/14/20

Significant decrease in both Ki67 status and its expression values in cases that received cytotoxic treatment. »
07/18/20

Race and comorbidities not associated with active surveillance. »
07/14/20

No interaction between tumor size and type of surgery found for patients with neuroendocrine tumors. »
03/26/20

No significant correlations seen between increased serum levels of CCL11 and CCL24 and efficacy of anti-PD1 antibodies. »
07/14/20

Those with clinical insomnia had significantly lower quality of life. »
02/18/20

Significant rate of patients will recover from I131 therapy salivary side effects. »
01/03/20

Apatinib single-agent use might be effective and tolerable choice as salvage therapy. »
03/10/20

Combinations of capmatinib and other kinase inhibitors resulted in enhanced anticancer activity. »
09/17/18

Preoperative CA19-9 levels significantly higher in low (GNRI ≤98; n=30) than the normal GNRI group. »
05/26/20